Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia

Nephrology Dialysis Transplantation

Volumn 18, Issue 12, 2003, Pages 2542-2550

  Nijveldt, Robert J ^a   Teerlink, Tom ^a   van Guldener, Coen ^a,b   Prins, Hubert A ^a   van Lambalgen, Antonie A ^a   Stehouwer, Coen D A ^a   Rauwerda, Jan A ^a   van Leeuwen, Paul A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

Author keywords

Kidney; L arginine; Nitric oxide; Nitric oxide synthase

Indexed keywords

ARGININE; CREATININE; DIMETHYLARGININASE; LIPOPOLYSACCHARIDE; MICROSPHERE; N(G),N(G) DIMETHYLARGININE; RUTHENIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTOXEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INFLAMMATION; ISOTOPE LABELING; KIDNEY BLOOD FLOW; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN METABOLISM; RAT; REGULATORY MECHANISM; URINARY EXCRETION; VEIN BLOOD FLOW;

ANIMALS; ARGININE; BIOLOGICAL TRANSPORT; ENDOTOXEMIA; ENZYME INHIBITORS; KIDNEY; LIPOPOLYSACCHARIDES; MALE; MICROSPHERES; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; RENAL CIRCULATION;

EID: 0344465408     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg452     Document Type: Article

References (30)

1. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20 [Suppl 12]: S60-S62
2. Matsuoka H, Itoh S, Kimoto M et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997; 29: 242-247
3. Bogle RG, MacAllister RJ, Whitley GS, Vallance P. Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases? Am J Physiol 1995; 269: C750-C756
4. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575
5. + carrier hCAT-2B. Nitric Oxide 1997; 1: 65-73
6. Tojo A, Welch WJ, Bremer V et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 1997; 52: 1593-1601
7. Boger RH, Bode-Boger SM, Szuba A et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847
8. Boger RH, Bode-Boger SM, Thiele W et al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95: 2068-2074
9. Miyazaki H, Matsuoka H, Cooke JP et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99: 1141-1146
10. Kang ES, Tevlin MT, Wang YB et al. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period. Am J Med Sci 1999; 317: 9-21
11. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037
12. MacAllister RJ, Rambausek MH, Vallance P et al. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 1996; 11: 2449-2452
13. Fleck C, Janz A, Schweitzer F et al. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int 2001; 59 [Suppl 78]: S14-S18
14. Nijveldt RJ, van Leeuwen PA, van Guldener C et al. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 2002; 17: 1999-2002
15. Kimoto M, Miyatake S, Sasagawa T et al. Purification, cDNA cloning and expression of human NG,NG-dimethylarginine dimethylaminohydrolase. Eur J Biochem 1998; 258: 863-868
16. Ogawa T, Kimoto M, Sasaoka K. Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 1989; 264: 10205-10209
17. Ogawa T, Kimoto M, Sasaoka K. Dimethylarginine:pyruvate aminotransferase in rats. Purification, properties, and identity with alanine:glyoxylate aminotransferase 2. J Biol Chem 1990; 265: 20938-20945
18. MacAllister RJ, Parry H, Kimoto M et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 1996; 119: 1533-1540
19. Murray-Rust J, Leiper J, McAlister M et al. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat Struct Biol 2001; 8: 679-683
20. Ito A, Tsao PS, Adimoolam S et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99: 3092-3095
21. National Institutes of Health. Guide for the Care and Use of Laboratory Animals, DHEW publication no. National Institutes of Health, 85-23. National Institutes of Health, Bethesda, MD, 1985
22. Idvall J, Aronsen KF, Nilsson L, Nosslin B. Evaluation of the microsphere method for determination of cardiac output and flow distribution in the rat. Eur Surg Res 1979; 11: 423-433
23. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002; 303: 131-137
24. van Lambalgen AA, van Kraats AA, Mulder MF et al. Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats. J Crit Care 1993;8: 117-127
25. Carnegie PR, Fellows FC, Symington GR. Urinary excretion of methylarginine in human disease. Metabolism 1977; 26: 531-537
26. Ogawa T, Kimoto M, Watanabe H, Sasaoka K. Metabolism of NG,NG- and NG,N′G-dimethylarginine in rats. Arch Biochem Biophys 1987; 252: 526-537
27. Feldhoff RC, Ledden DJ, Steffen MC, Steffen JM, Musacchia XJ. Analysis of 1- and 3-methylhistidines, aromatic and basic amino acids in rat and human urine. J Chromatogr 1984; 311: 267-276
28. Hattori Y, Kasai K, Gross SS. Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 1999; 276: H2020-H2028
29. Prins HA, Houdijk AP, Wiezer MJ et al. Reduced arginine plasma levels are the drive for arginine production by the kidney in the rat. Shock 1999; 11: 199-204
30. Hallemeesch MM, Cobben DC, de Jong CH, Soeters PB, Deutz NE. Renal amino acid metabolism during endotoxemia in the rat. J Surg Res 2000; 92: 193-200